232 related articles for article (PubMed ID: 32363586)
41. Baseline Serum neutrophil-to-lymphocyte ratio in acral melanoma compared with nonacral melanoma and its prognostic significance.
Choi ME; Jung JM; Kim DH; Won CH; Chang SE; Lee MW; Lee WJ
J Am Acad Dermatol; 2024 May; 90(5):977-985. PubMed ID: 38272394
[TBL] [Abstract][Full Text] [Related]
42. Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous Melanoma.
Cho WC; Wang WL; Milton DR; Ingram DR; Nagarajan P; Curry JL; Ivan D; Lazar AJ; Hwu WJ; Prieto VG; Torres-Cabala CA; Aung PP
Arch Pathol Lab Med; 2021 Jul; 145(7):842-850. PubMed ID: 33053175
[TBL] [Abstract][Full Text] [Related]
43. Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis.
Kolla AM; Vitiello GA; Friedman EB; Sun J; Potdar A; Daou H; Farrow NE; Farley CR; Vetto JT; Han D; Tariq M; Beasley GM; Contreras CM; Lowe M; Zager JS; Osman I; Berman RS; Liebman TN; Stein JA; Lee AY
Cancer Control; 2021; 28():10732748211053567. PubMed ID: 34752172
[TBL] [Abstract][Full Text] [Related]
44. Survival of acral lentiginous melanoma in the National Cancer Institute of Colombia.
Duarte CA; Flórez JP; López HG; Meneses MX; de Vries E
J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):438-442. PubMed ID: 27518480
[TBL] [Abstract][Full Text] [Related]
45. The current management and prognosis of acral lentiginous melanoma.
Wells KE; Reintgen DS; Cruse CW
Ann Plast Surg; 1992 Jan; 28(1):100-3. PubMed ID: 1642394
[TBL] [Abstract][Full Text] [Related]
46. Major Histotypes in Skin Melanoma: Nodular and Acral Lentiginous Melanomas Are Poor Prognostic Factors for Relapse and Survival.
Tas F; Erturk K
Am J Dermatopathol; 2022 Nov; 44(11):799-805. PubMed ID: 35925149
[TBL] [Abstract][Full Text] [Related]
47. Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma.
Sheen YS; Liao YH; Lin MH; Chiu HC; Jee SH; Liau JY; Chang YL; Chu CY
PLoS One; 2016; 11(1):e0147431. PubMed ID: 26796627
[TBL] [Abstract][Full Text] [Related]
48. Does sentinel lymph node status have prognostic significance in patients with acral lentiginous melanoma?
Pavri SN; Han G; Khan S; Han D
J Surg Oncol; 2019 Jun; 119(8):1060-1069. PubMed ID: 30883783
[TBL] [Abstract][Full Text] [Related]
49. Acral cutaneous melanoma in a Spanish Caucasian population.
Avilés-Izquierdo JA; Longo-Imedio MI; Lázaro-Ochaita P
Melanoma Res; 2010 Jun; ():. PubMed ID: 20585270
[TBL] [Abstract][Full Text] [Related]
50. Acral Lentiginous Melanoma of Foot and Ankle: A Clinicopathological Study of 7 Cases.
Hao X; Yim J; Chang S; Schwartz E; Rubenstein S; Friske C; Shamim S; Masternick E; Mirkin G
Anticancer Res; 2019 Nov; 39(11):6175-6181. PubMed ID: 31704845
[TBL] [Abstract][Full Text] [Related]
51. Surgical management of primary cutaneous melanomas of the hands and feet.
Tseng JF; Tanabe KK; Gadd MA; Cosimi AB; Malt RA; Haluska FG; Mihm MC; Sober AJ; Souba WW
Ann Surg; 1997 May; 225(5):544-50; discussion 550-3. PubMed ID: 9193182
[TBL] [Abstract][Full Text] [Related]
52. Biological behavior and natural course of acral malignant melanoma. Clinical and histologic features and prognosis of palmoplantar, subungual, and other acral malignant melanomas.
Jimbow K; Takahashi H; Miura S; Ikeda S; Kukita A
Am J Dermatopathol; 1984; 6 Suppl():43-53. PubMed ID: 6528942
[TBL] [Abstract][Full Text] [Related]
53. Acral lentiginous melanoma: a single-centre retrospective review of four decades in East-Central Europe.
Csányi I; Houshmand N; Szűcs M; Ócsai H; Kemény L; Oláh J; Baltás E
J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):2004-2010. PubMed ID: 31989672
[TBL] [Abstract][Full Text] [Related]
54. Subungual melanoma. A clinicopathologic study of 16 Japanese cases.
Takematsu H; Obata M; Tomita Y; Kato T; Takahashi M; Abe R
Cancer; 1985 Jun; 55(11):2725-31. PubMed ID: 3995482
[TBL] [Abstract][Full Text] [Related]
55. Analysis of recurrence patterns in acral versus nonacral melanoma: should histologic subtype influence treatment guidelines?
Gumaste PV; Fleming NH; Silva I; Shapiro RL; Berman RS; Zhong J; Osman I; Stein JA
J Natl Compr Canc Netw; 2014 Dec; 12(12):1706-12. PubMed ID: 25505211
[TBL] [Abstract][Full Text] [Related]
56. [Is acrolentiginous melanoma (ALM) more malignant than superficially spreading melanoma (SSM) at a high-risk site? A matched-pair comparison between 113 ALM and SSM within the scope of a multicenter study].
Breuninger H; Köhler C; Drepper H; Bastian B; Bröcker EB; Göhl J; Groth W; Hermanek P; Hohenberger W; Lippold A
Hautarzt; 1994 Aug; 45(8):529-31. PubMed ID: 7960751
[TBL] [Abstract][Full Text] [Related]
57. Acral lentiginous melanoma: conventional histology vs. three-dimensional histology.
Lichte V; Breuninger H; Metzler G; Haefner HM; Moehrle M
Br J Dermatol; 2009 Mar; 160(3):591-9. PubMed ID: 19067697
[TBL] [Abstract][Full Text] [Related]
58. Unique prognostic factors in acral lentiginous melanoma.
Egger ME; McMasters KM; Callender GG; Quillo AR; Martin RC; Stromberg AJ; Scoggins CR
Am J Surg; 2012 Dec; 204(6):874-9; discussion 879-80. PubMed ID: 23022254
[TBL] [Abstract][Full Text] [Related]
59. Melanomas of the palm, sole, and nailbed: a clinicopathologic study.
Feibleman CE; Stoll H; Maize JC
Cancer; 1980 Dec; 46(11):2492-504. PubMed ID: 7438021
[TBL] [Abstract][Full Text] [Related]
60. Histological type and biological behavior of primary cutaneous malignant melanoma. 2. An analysis of 86 cases located on so-called acral regions as plantar, palmar, and sub-/parungual areas.
Søndergaard K
Virchows Arch A Pathol Anat Histopathol; 1983; 401(3):333-43. PubMed ID: 6415910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
